Changes of cytoskeletal proteins in nerve tissues and serum of rats treated with 2,5-hexanedione

Toxicology

Volumn 244, Issue 2-3, 2008, Pages 166-178

  Wang, Qing Shan ^a   Hou, Li Yan ^a   Zhang, Cui Li ^a   Song, Fu Yong ^a   Xie, Ke Qin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

2,5 Hexanedione; Biomarker; Cytoskeletal protein; Neurofilament; Neuropathy

Indexed keywords

ACETONYLACETONE; ALPHA TUBULIN; BETA ACTIN; BETA TUBULIN; CYTOSKELETON PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORRELATION ANALYSIS; GAIT DISORDER; INTOXICATION; MALE; MICROFILAMENT; MICROTUBULE; NERVOUS TISSUE; NEUROFILAMENT; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL CORD; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; WISTAR RAT;

ACTINS; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BODY WEIGHT; CEREBRAL CORTEX; CYTOSKELETAL PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEXANONES; LAMENESS, ANIMAL; MALE; MICROFILAMENT PROTEINS; MICROTUBULE PROTEINS; NERVE TISSUE; NEUROFILAMENT PROTEINS; NEUROTOXICITY SYNDROMES; NEUROTOXINS; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; SCIATIC NERVE; SOLVENTS; SUBSTANTIA NIGRA; TUBULIN;

RATTUS; RATTUS NORVEGICUS;

EID: 38749101956     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.11.009     Document Type: Article

References (56)

1. Banik N.L., Hogan E.L., Powers J.M., and Whetstine L.J. Degradation of cytoskeletal proteins in spinal cord injury. Neurochem. Res. 7 (1982) 1465-1475
2. Banik N.L., Matzelle D.C., Gantt-Wilford G., Osborne A., and Hogan E.L. Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 752 (1997) 301-306
3. Carden M.J., Lee V.M., and Schlaepfer W.W. 2,5-Hexanedione neuropathy is associated with the covalent crosslinking of neurofilament proteins. Neurochem. Pathol. 5 (1986) 25-35
4. Chiu F.C., and Norton W.T. Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament proteins by gel filtration: dye-binding characteristics and amino acid compositions. J. Neurochem. 39 (1982) 1252-1260
5. Chiu F.C., Opanashuk L.A., He D.K., Lehning E.J., and LoPachin R.M. Gamma-diketone peripheral neuropathy. II. Neurofilament subunit content. Toxicol. Appl. Pharmacol. 165 (2000) 141-147
6. Costa L.G., and Manzo L. Biochemical markers of neurotoxicity: research strategies and epidemiological applications. Toxicol. Lett. 77 (1995) 137-144
7. dos Santos C.R., Meyer Passarelli M.M., and de Souza Nascimento E. Evaluation of 2,5-hexanedione in urine of workers exposed to n-hexane in Brazilian shoe factories. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 778 (2002) 237-244
8. Fedtke N., and Bolt H.M. Detection of 2,5-hexanedione in the urine of persons not exposed to n-hexane. Int. Arch. Occup. Environ. Health 57 (1986) 143-148
9. Fliegner K.H., and Liem R.K. Cellular and molecular biology of neuronal intermediate filaments. Int. Rev. Cytol. 131 (1991) 109-167
10. Gilbert S.G., and Maurissen J.P. Assessment of the effects of acrylamide, methylmercury, and 2,5-hexanedione on motor functions in mice. J. Toxicol. Environ. Health 10 (1982) 31-41
11. Graham D.G., Amarnath V., Valentine W.M., Pyle S.J., and Anthony D.C. Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit. Rev. Toxicol. 25 (1995) 91-112
12. Greenwood J.A., Troncoso J.C., Costello A.C., and Johnson G.V. Phosphorylation modulates calpain-mediated proteolysis and calmodulin binding of the 200-kDa and 160-kDa neurofilament proteins. J. Neurochem. 61 (1993) 191-199
13. Guo X., Wang Q.S., Zhang L.P., Zhu Y.J., and Xie K.Q. The time-dependent changes of electrophysiological parameters in 2,5-Hexanedione-treated rats. J. Toxicol. 19 (2005) 293-294
14. Iwata M., Takeuchi Y., Hisanaga N., and Ono Y. Changes of n-hexane neurotoxicity and its urinary metabolites by long-term co-exposure with MEK or toluene. Int. Arch. Occup. Environ. Health 54 (1984) 273-281
15. Jellinger K.A. Cell death mechanisms in neurodegeneration. J. Cell Mol. Med. 5 (2001) 1-17
16. Jung C., and Shea T.B. Regulation of neurofilament axonal transport by phosphorylation in optic axons in situ. Cell Motil. Cytoskeleton 42 (1999) 230-240
17. Jung C., Yabe J.T., and Shea T.B. C-terminal phosphorylation of the high molecular weight neurofilament subunit correlates with decreased neurofilament axonal transport velocity. Brain Res. 856 (2000) 12-19
18. Karlsson J.E., Rosengren L.E., and Haglid K.G. Quantitative and qualitative alterations of neuronal and glial intermediate filaments in rat nervous system after exposure to 2,5-hexanedione. J. Neurochem. 57 (1991) 1437-1444
19. Kawai T., Mizunuma K., Yasugi T., Uchida Y., and Ikeda M. The method of choice for the determination of 2,5-hexanedione as an indicator of occupational exposure to n-hexane. Int. Arch. Occup. Environ. Health 62 (1990) 403-408
20. Lagorio S., Tagesson C., Forastiere F., Iavarone I., Axelson O., and Carere A. Exposure to benzene and urinary concentrations of 8-hydroxydeoxyguanosine, a biological marker of oxidative damage to DNA. Occup. Environ. Med. 51 (1994) 739-743
21. Lapadula D.M., Suwita E., and Abou-Donia M.B. Cross-linking of neurofilament proteins of rat spinal cord in vivo after administration of 2,5-hexanedione. J. Neurochem. 46 (1986) 1843-1850
22. Lapadula D.M., Suwita E., and Abou-Donia M.B. Evidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy. Brain Res. 458 (1988) 123-131
23. Lehning E.J., Dyer K.S., Jortner B.S., and LoPachin R.M. Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy. Toxicol. Appl. Pharmacol. 135 (1995) 58-66
24. Lehning E.J., Jortner B.S., Fox J.H., Arezzo J.C., Kitano T., and LoPachin R.M. Gamma-diketone peripheral neuropathy. I. Quality morphometric analyses of axonal atrophy and swelling. Toxicol. Appl. Pharmacol. 165 (2000) 127-140
25. Liem R.K. Molecular biology of neuronal intermediate filaments. Curr. Opin. Cell Biol. 5 (1993) 12-16
26. Liuzzi F.J., Bufton S.M., and Vinik A.I. Streptozotocin-induced diabetes mellitus causes changes in primary sensory neuronal cytoskeletal mRNA levels that mimic those caused by axotomy. Exp. Neurol. 154 (1998) 381-388
27. LoPachin R.M., Ross J.F., Reid M.L., Das S., Mansukhani S., and Lehning E.J. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione. Neurotoxicology 23 (2002) 95-110
28. LoPachin R.M., He D., Reid M.L., and Opanashuk L.A. 2,5-Hexanedione-induced changes in the monomeric neurofilament protein content of rat spinal cord fractions. Toxicol. Appl. Pharmacol. 198 (2004) 61-73
29. LoPachin R.M., He D., and Reid M.L. 2,5-Hexanedione-induced changes in the neurofilament subunit pools of rat peripheral nerve. Neurotoxicology 26 (2005) 229-240
30. Mayan O., Teixeira J.P., Alves S., and Azevedo C. Urinary 2,5-hexanedione as a biomarker of n-hexane exposure. Biomarkers 7 (2002) 299-305
31. Mercier M.J., and Robinson A.E. Use of biologic markers for toxic end-points in assessment of risks from exposure to chemicals. Int. Arch. Occup. Environ. Health. 65 (1993) S7-S10
32. Micheva K.D., Vallee A., Beaulieu C., Herman I.M., and Leclerc N. Beta-actin is confined to structures having high capacity of remodeling in developing and adult rat cerebellum. Eur. J. Neurosci. 10 (1998) 3785-3798
33. Monaco S., Jacob J., Jenich H., Patton A., Autilio-Gambetti L., and Gambetti P. Axonal transport of neurofilament is accelerated in peripheral nerve during 2,5-hexanedione intoxication. Brain Res. 491 (1989) 328-334
34. Opanashuk L.A., He D.K., Lehning E.J., and Lopachin R.M. Gamma-diketone peripheral neuropathy. III. Neurofilament gene expression. Neurotoxicology 22 (2001) 215-220
35. Perbellini L., Amantini M.C., Brugnone F., and Frontali N. Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey. Arch. Toxicology 50 (1982) 203-215
36. Prieto M.J., Marhuenda D., Roel J., and Cardona A. Free and total 2,5-hexanedione in biological monitoring of workers exposed to n-hexane in the shoe industry. Toxicol. Lett. 145 (2003) 249-260
37. Ramaekers F.C., and Bosman F.T. The cytoskeleton and disease. J. Pathol. 204 (2004) 351-354
38. Rao M.V., Houseweart M.K., Williamson T.L., Crawford T.O., Folmer J., and Cleveland D.W. Neurofilament-dependent radial growth of motor axons and axonal organization of neurofilaments does not require the neurofilament heavy subunit (NF-H) or its phosphorylation. J. Cell Biol. 143 (1998) 171-181
39. Ripova D., and Strunecka A. An ideal biological marker of Alzheimer's disease: dream or reality?. Physiol. Res. 50 (2001) 119-129
40. Sakaguchi T., Okada M., Kitamura T., and Kawasaki K. Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail. Neurosci. Lett. 153 (1993) 65-68
41. Schlaepfer W.W., Lee C., Lee V.M., and Zimmerman U.J. An immunoblot study of neurofilament degradation in situ and during calcium-activated proteolysis. J. Neurochem. 44 (1985) 502-509
42. Semra Y.K., Seidi O.A., and Sharief M.K. Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability. J. Neuroimmunol. 122 (2002) 132-139
43. Shibata E., Huang J., Ono Y., Hisanaga N., Iwata M., Saito I., and Takeuchi Y. Changes in urinary n-hexane metabolites by co-exposure to various concentrations of methyl ethyl ketone and fixed n-hexane levels. Arch. Toxicol. 64 (1990) 165-168
44. Shibata E., Johanson G., Löf A., Ernstgård L., Gullstrand E., and Sigvardsson K. Changes in n-hexane toxicokinetics in short-term single exposure due to co-exposure to methyl ethyl ketone in volunteers. Int. Arch. Occup. Environ. Health. 75 (2002) 399-405
45. Song F., Yu S., Zhao X., Zhang C., and Xie K. Carbon disulfide-induced changes in cytoskeleton protein content of rat cerebral cortex. Neurochem. Res. 31 (2006) 71-79
46. Spencer P.S., and Schaumburg H.H. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. J. Neuropathol. Exp. Neurol. 36 (1977) 276-299
47. Stone J.D., Peterson A.P., Eyer J., Oblak T.G., and Sickles D.W. Neurofilaments are nonessential to the pathogenesis of toxicant-induced axonal degeneration. J. Neurosci. 21 (2001) 2278-2287
48. Strong M.J., Strong W.L., Jaffe H., Traggert B., Sopper M.M., and Pant H.C. Phosphorylation state of the native high-molecular-weight neurofilament subunit protein from cervical spinal cord in sporadic amyotrophic lateral sclerosis. J. Neurochem. 76 (2001) 1315-1325
49. Teunissen C.E., Dijkstra C., and Polman C. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol. 4 (2005) 32-41
50. Watson D.F., Fittro K.P., Hoffman P.N., and Griffin J.W. Phosphorylation-related immunoreactivity and the rate of transport of neurofilaments in chronic 2,5-hexanedione intoxication. Brain Res. 539 (1991) 103-109
51. Xu Z., Dong D.L., and Cleveland D.W. Neuronal intermediate filaments: new progress on an old subject. Curr. Opin. Neurobiol. 4 (1994) 655-661
52. Yabe J.T., Chan W.K., Chylinski T.M., Lee S., Pimenta A.F., and Shea T.B. The predominant form in which neurofilament subunits undergo axonal transport varies during axonal initiation, elongation and maturation. Cell Motil. Cytoskeleton 48 (2001) 61-83
53. Yabe J.T., Chylinski T., Wang F.S., Pimenta A., Kattar S.D., Linsley M.D., Chan W.K., and Shea T.B. Neurofilaments consist of distinct populations that can be distinguished by C-terminal phosphorylation, bundling, and axonal transport rate in growing axonal neurites. J. Neurosci. 21 (2001) 2195-2205
54. Yagihashi S., Kamijo M., and Watanabe K. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. Am. J. Pathol. 136 (1990) 1365-1373
55. Yang Y., Bauer C., Strasser G., Wollman R., Julien J.P., and Fuchs E. Integrators of the cytoskeleton that stabilize microtubules. Cell 98 (1999) 229-238
56. Zhang T., Zhao X., Zhu Z., Yu L., Han X., Zhang C., and Xie K. 2,5-Hexanedione induced decrease in cytoskeletal proteins of rat sciatic-tibial nerve. Neurochem. Res. 30 (2005) 177-183